nevirapine has been researched along with cepharanthine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Baba, M; Okamoto, M; Okamoto, T | 1 |
| Back, DJ; Brockmeyer, NH; Fätkenheuer, G; Hoffmann, C; Hopper-Borge, E; Khoo, SH; Knechten, H; Liptrott, NJ; Mauss, S; Owen, A; Pirmohamed, M; Pushpakom, S; Siccardi, M; Wyen, C | 1 |
3 other study(ies) available for nevirapine and cepharanthine
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells.
Topics: Alkaloids; Anti-HIV Agents; Anti-Infective Agents; Benzylisoquinolines; Cell Line; Drug Synergism; Fluoroquinolones; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Nelfinavir; Nevirapine; NF-kappa B; Piperazines; Reverse Transcriptase Inhibitors; Tumor Necrosis Factor-alpha; Virus Replication; Zidovudine | 1999 |
Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Benzylisoquinolines; Biomarkers, Pharmacological; CD4-Positive T-Lymphocytes; Gene Expression; HEK293 Cells; Humans; Linear Models; Macrophages; Middle Aged; Multidrug Resistance-Associated Proteins; Nevirapine; Polymorphism, Single Nucleotide; RNA, Small Interfering | 2012 |